Market Size of Microbiology Testing Industry
Study Period | 2021 - 2029 |
Market Size (2024) | USD 5.65 Billion |
Market Size (2029) | USD 8.78 Billion |
CAGR (2024 - 2029) | 9.22 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Microbiology Testing Market Analysis
The Microbiology Testing Market size is estimated at USD 5.65 billion in 2024, and is expected to reach USD 8.78 billion by 2029, growing at a CAGR of 9.22% during the forecast period (2024-2029).
With the COVID-19 outbreak, there was a surge in demand for COVID-19-related diagnostic kits, assay reagents, equipment, and services initially, which had a significant impact on microbiology testing services. For instance, according to an article published by PubMed Central in September 2022, during the pandemic in early 2020, many clinical microbiology laboratories experienced backorders and supply chain issues for many routine tests and associated testing supplies, such as swabs, transport media, and extraction reagents. Laboratories experienced staffing shortages as more trained technologists were needed to meet the demand for continuous SARS-CoV-2 testing and staffing was also limited to reduce exposure risk or for quarantine. So, the COVID-19 pandemic had a significant impact on the market initially, however, currently as the pandemic has subsided and fewer people are getting infected with the virus, fewer diagnostic tests are needed for COVID-19. Moreover, the diagnosis of other diseases has increased and hence, the studied market has started to gain traction and it is expected to have stable growth during the forecast period of the study.
The propelling factors for the growth of the microbiology testing market include technological advancements in microbiology testing, rising incidences of infectious diseases, growing healthcare expenditure, and rising private-public funding for research on infectious diseases.
Infectious diseases, such as HIV, human papillomavirus (HPV), and hepatitis B and C, are some forms of STDs that are severe and fatal, and thus the increasing incidences of such diseases are increasing the demand for the microbiology testing market. For instance, according to an article published by the virology journal in September 2022, human papillomavirus (HPV) is considered one of the most commonly encountered sexually transmitted infections, which is responsible for causing cervical cancer and other cancers including vaginal, vulvar, anal, penile, and oropharyngeal cancer. More than 200 HPV genotypes have been identified, and they can be classified into high-risk (HR) and low-risk HPV (LR) genotypes based on their carcinogenicity. Furthermore, increasing healthcare expenditure and the presence of better medical infrastructures, such as hospitals and clinical labs, are some other drivers augmenting the growth of the microbiology testing market.
Additionally, as per the data published by the WHO in August 2022, more than 1 million sexually transmitted infections are acquired globally every day and most of them are asymptomatic. It also reported that every year there are an estimated 374 million new infections with 1 out of 4 sexually transmitted infections such as gonorrhea, chlamydia, trichomoniasis, and syphilis.
The market players are adopting various strategies such as acquisitions, collaborations, partnerships, and expansions of services to increase market share. For instance, in June 2022, STEMart launched microbiology and sterility testing for sterile and non-pyrogenic medical devices. Hence, increasing service launches by key market players are expected to enhance the market growth during the forecast period of the study.
Thus, the factors such as increasing incidence of infectious diseases and various strategies adopted by market players such as acquisitions, collaborations, partnerships, and expansions of services are expected to drive the growth of the microbiology testing market. However, factors such as laboratory reimbursement issues and the high cost of microbiology instruments may impede market growth in the near future.
Microbiology Testing Industry Segmentation
As per the scope of the report, microbial testing is an analytical technique that is utilized to determine the number of microorganisms in food, beverages, biological samples, and environmental samples. The microbial testing technique employs chemical, biological, biochemical, or molecular methods to identify and quantify the microbes. It is one of the important processes carried out in the medical, healthcare, and food industries for the prevention of future product damage. The Microbiology Testing Market is segmented by Application (Pharmaceutical Application, Diagnostic Application, Food and Beverage Testing Application, Environmental Application, Cosmetic Application, Other Applications), Product (Equipment and Reagents), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
By Application | |
Pharmaceutical Application | |
Diagnostic Application | |
Food and Beverage Testing Application | |
Environmental Application | |
Cosmetic Application | |
Other Applications |
By Product | |
Equipment | |
Reagents |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Microbiology Testing Market Size Summary
The microbiology testing market is poised for significant growth, driven by technological advancements and an increasing incidence of infectious diseases. The market experienced an initial surge in demand due to the COVID-19 pandemic, which highlighted the critical role of microbiology testing in disease diagnosis and management. As the pandemic's impact wanes, the focus has shifted towards diagnosing other infectious diseases, thereby stabilizing and propelling market growth. Factors such as rising healthcare expenditure, enhanced medical infrastructure, and increased funding for infectious disease research are further fueling the market's expansion. The demand for testing is particularly high for sexually transmitted infections like HIV and HPV, which are prevalent globally and require accurate and rapid diagnostic methods.
In North America, the microbiology testing market is experiencing robust growth due to well-established healthcare infrastructure and a rising burden of infectious diseases. The region benefits from significant investments in research and development, particularly in antimicrobial resistance, which supports market expansion. Key players in the market are actively engaging in strategies such as product launches, acquisitions, and collaborations to enhance their market presence and offer advanced testing solutions. The competitive landscape is characterized by the introduction of automated systems that improve testing efficiency and accuracy. Companies like Bio-Rad Laboratories, Abbott Laboratories, and Bruker Corporation are at the forefront, driving innovation and expanding their service offerings to meet the growing demand for microbiology testing.
Microbiology Testing Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Technological Advancements in Microbiology Testing
-
1.2.2 Rising Burden of Infectious Diseases and Outbreak of Epidemics
-
1.2.3 Rising Private-Public Funding for Research on Infectious Diseases
-
-
1.3 Market Restraints
-
1.3.1 Laboratory Reimbursement Issues
-
1.3.2 High Cost of Microbiology Instruments
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Application
-
2.1.1 Pharmaceutical Application
-
2.1.2 Diagnostic Application
-
2.1.3 Food and Beverage Testing Application
-
2.1.4 Environmental Application
-
2.1.5 Cosmetic Application
-
2.1.6 Other Applications
-
-
2.2 By Product
-
2.2.1 Equipment
-
2.2.2 Reagents
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Microbiology Testing Market Size FAQs
How big is the Microbiology Testing Market?
The Microbiology Testing Market size is expected to reach USD 5.65 billion in 2024 and grow at a CAGR of 9.22% to reach USD 8.78 billion by 2029.
What is the current Microbiology Testing Market size?
In 2024, the Microbiology Testing Market size is expected to reach USD 5.65 billion.